SCHEMBL5164430

SCHEMBL5164430

C[n+]1ccc(C(=O)c2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.64
L3MBTL1 Q9Y468 3/20 0.54
ATM Q13315 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
SRD5A2 P31213 1/20 0.54
APOBEC3A P31941 2/20 0.51
CTDSP1 Q9GZU7 2/20 0.51
APOBEC3G Q9HC16 2/20 0.51
RAB9A P51151 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
HPGD P15428 2/20 0.50
NPC1 O15118 1/20 0.50
SLC22A2 O15244 1/20 0.50
SLC22A1 O15245 1/20 0.50
SLC22A3 O75751 1/20 0.50
SLC6A4 P31645 1/20 0.50
ELANE P08246 1/20 0.48
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5694419 0.89 ALDH1A1 (0.50) ALDH1A1L3MBTL1ATMTDP1SRD5A2
SCHEMBL15423843 0.88 RAB9A (0.60) ALDH1A1L3MBTL1ATMTDP1SRD5A2
SCHEMBL6150355 0.86 ALDH1A1 (0.47) ALDH1A1L3MBTL1ATMTDP1SRD5A2
SCHEMBL10256967 0.81 NNMT (0.63) ALDH1A1L3MBTL1ATMTDP1SRD5A2
SCHEMBL7050135 0.80 RECQL (0.47) ALDH1A1TDP1SRD5A2LMNAAKR1C3
Benzophenone SCHEMBL7454682 0.80 ALDH1A1 (0.88) ALDH1A1L3MBTL1ATMTDP1SRD5A2
Benzophenone SCHEMBL28491203 0.80 ALDH1A1 (1.00) ALDH1A1L3MBTL1ATMTDP1SRD5A2
Benzophenone SCHEMBL30536983 0.80 ALDH1A1 (1.00) ALDH1A1L3MBTL1ATMTDP1SRD5A2
Benzophenone SCHEMBL30537001 0.80 ALDH1A1 (1.00) ALDH1A1L3MBTL1ATMTDP1SRD5A2
Benzophenone SCHEMBL6061130 0.80 ALDH1A1 (1.00) ALDH1A1L3MBTL1ATMTDP1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758546-B1 USE OF SPECIAL POLYOLS FOR INHIBITING THE CRYSTALLIZATION OF ONIUM ALDEHYDES AND ONIUM KETONES HENKEL KGAA (DE) 2007-09-05 EP claimed
EP-1758546-A1 USE OF SPECIAL POLYOLS FOR INHIBITING THE CRYSTALLIZATION OF ONIUM ALDEHYDES AND ONIUM KETONES Henkel Kommanditgesellschaft auf Aktien (DE) 2007-03-07 EP claimed
WO-2005115322-A1 USE OF SPECIAL POLYOLS FOR INHIBITING THE CRYSTALLIZATION OF ONIUM ALDEHYDES AND ONIUM KETONES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2005-12-08 WO claimed
EP-1575539-A1 DYE TABLETS Henkel Kommanditgesellschaft auf Aktien (DE) 2005-09-21 EP claimed
EP-1037586-B1 UTILIZATION OF ONIUM ALDEHYDES AND ONIUM KETONES FOR DYING FIBERS CONTAINING KERATIN HENKEL KGAA (DE) 2004-12-22 EP claimed
WO-2004058202-A1 DYE TABLETS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2004-07-15 WO claimed
EP-1434552-A1 METHOD FOR DYEING KERATINOUS FIBRES Henkel Kommanditgesellschaft auf Aktien (DE) 2004-07-07 EP claimed
EP-1433785-A1 Agents for the coloration of keratinous fibres Henkel Kommanditgesellschaft auf Aktien (DE) 2004-06-30 EP claimed
WO-2003030841-A1 METHOD FOR DYEING KERATINOUS FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 WO claimed
US-6371993-B1 HAIR DYES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2002-04-16 US claimed
EP-1037586-A1 UTILIZATION OF ONIUM ALDEHYDES AND ONIUM KETONES FOR DYING FIBERS CONTAINING KERATIN Henkel Kommanditgesellschaft auf Aktien (DE) 2000-09-27 EP claimed
WO-1999018916-A2 UTILIZATION OF ONIUM ALDEHYDES AND ONIUM KETONES FOR DYING FIBERS CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1999-04-22 WO claimed
CN-103116246-B A kind of photosensitive polymer combination and application thereof 村上精密制版(昆山)有限公司 2016-07-06 CN disclosed
US-20130143928-A1 BIS-PYRINIDIUM COMPOUNDS THE UNIVERSITY OF SYDNEY (AU) 2013-06-06 US disclosed
US-20120015925-A1 NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS ASAHI KASEI PHARMA CORPORATION (JP) 2012-01-19 US disclosed
EP-1535913-B1 NOVEL QUATERNARY AMMONIUM COMPOUNDS ASAHI KASEI PHARMA CORP (JP) 2011-11-02 EP disclosed
US-6371993-B1 HAIR DYES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2002-04-16 US disclosed
EP-1037586-A1 UTILIZATION OF ONIUM ALDEHYDES AND ONIUM KETONES FOR DYING FIBERS CONTAINING KERATIN Henkel Kommanditgesellschaft auf Aktien (DE) 2000-09-27 EP disclosed
WO-1999018916-A2 UTILIZATION OF ONIUM ALDEHYDES AND ONIUM KETONES FOR DYING FIBERS CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1999-04-22 WO disclosed
US-4182797-A AS CATHODE WITH LITHIUM ANODE, LITHIUM IODIDE ELECTROLYTE; USED FOR PACRMAKERS MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1980-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015925-A1 NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS SLC10A1, SREBF1, SPTLC1 ALDH1A1 1261/4885L3MBTL1 981/4885ATM 2537/4885
US-20130143928-A1 BIS-PYRINIDIUM COMPOUNDS PNPO, DHFR, PLPBP ALDH1A1 2353/4885L3MBTL1 681/4885ATM 1679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.